Parse Biosciences, Inc. vs 10x Genomics, Inc.

Petitioner Parse Biosciences, Inc.'s Supplemental Power of Attorney for Concord Cheung

Petitioner Parse Biosciences, Inc.'s Supplemental Mandatory Notice Adding Backup Counsel Under 37 C.F.R. Section 42.8(a)(3)

Patent Owner's Notice of Appeal

Judgment Final Written Decision

Other: Hearing transcript

Patent Owner's Submission of Unresolved Objections to Petitioner's Demonstratives

Patent Owner's Oral Hearing Demonstratives

Petitioner's Oral Argument Demonstratives

Patent Owner's Reply in Support of its Motion to Exclude

EX2041 - Wayback Archive Records for https://link.springer.com/article/10.1007/s10528-007-9114-x

EX2042 - Wayback Archive Records for https://pubmed.ncbi.nlm.nih.gov/17955361/

EX2043 - Wayback Archive Records for https://www.researchgate.net/publication/5891130_Encoding_PCR_Products_with _Batch-stamps_and_Barcodes

Petitioner's Reply to Patent Owner's Opposition to Motion to Exclude

Patent Owner's Opposition to Petitioner's Motion to Exclude

Petitioner's Opposition to Patent Owner's Motion to Exclude

EX1090

Patent Owner's Motion to Exclude

Petitioner's Motion to Exclude

Order Setting Oral Argument

Petitioner's Objections to Evidence

Patent Owner's Request for Oral Hearing

Petitioner's Request for Oral Argument

Patent Owner's Sur-Reply

EX2040 - IPR2023-00955 September 3, 2024 Deposition Transcript of Gregory Cooper, Ph.D.

EX2102 - C. Wansgasnuwat et al, Efficient and cost-effective bacterial mRNA sequencing from low input samples through ribosomal RNA depletion, BMC Genomics (2020) 21:717 (marked as EX2102 in Dr. Cooper’s September 3, 2024 deposition (EX2040))

V. Llorens-Rico et al, Single-cell approaches in human microbiome research, Cell (2022) 185:2725 (marked as EX2103 in Dr. Cooper’s September 3, 2024 deposition (EX2040))

Deposition Notice of Gregory Cooper, Ph.D.

Petitioner's Notice of Filing Stipulation Regarding Defenses in Co-Pending District Court Litigation

EX1088

EX1089

ORDER Granting Patent Owner’s Motion to Terminate Proceeding But Holding Termination in Abeyance Pending Action by Petitioner 37 C.F.R. § 42.5

Patent Owner's Objections to Evidence

Patent Owner's Reply in Support of its Motion to Terminate Proceedings

Petitioner's Reply to Patent Owner's Response

EX1069

EX1070

EX1071

EX1072

EX1073

EX1074

EX1075

EX1076

EX1079

EX1080

EX1081

EX1082

EX1083

EX1084

EX1085

EX1086

EX1087

Petitioner's Response to Patent Owner's Motion to Terminate Proceedings

Patent Owner's Motion to Terminate Proceedings

EX2023 - Excerpt of 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 001 (D. Del. Aug. 24, 2022) (Complaint)

EX2024 - Excerpt of Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-00878, Pap.1 (Apr. 20, 2023)

EX2025 - Excerpt of Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-00958, Pap.1 (May 25, 2023)

EX2026 - Excerpt of Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-01030, Pap.1 (June 06, 2023)

EX2027 - Excerpt of Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-01033, Pap.1 (June 06, 2023)

EX2030 - 10x Genomics, Inc. et al. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 121 (D. Del. Dec. 21, 2023) (Order Denying Motion to Stay)

EX2031 - Excerpt of Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-00958, Pap.8 (Jan. 05, 2024) (Rehearing Request)

EX2032 - 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 048 (D. Del. Mar. 07, 2023) (Scheduling Order)

EX2034 - 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 164 (D. Del. Feb. 20, 2024) (Order Denying Parse Renewed Motion to Stay)

EX2035 - Excerpt of 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 229 (D. Del. June 12, 2024) (Parse’s Op-position to 10x Ltr. re Motion to Strike Portions of Cooper Re-port; Ex. A: Sept. 19, 2023 Parse First Amended Invalidity Con-tention; Ex. B: Apr. 16, 2024 Parse Second Amended Invalidity Contention)

EX2036 - Excerpt of 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 218 (D. Del. May 30) (10x Ltr. re Motion to Strike Portions of Cooper Report; Ex. A: May 17, 2024 Expert Report of Dr. Gregory Cooper Regarding Invalidity (Excerpted))

EX2037 - 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, May 21, 2024 Email from J. Reich to D. Walter re Cooper Report

EX2038 - 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, May 28, 2024 Email from D. Walter to J. Reich re Cooper Report

EX2039 - 10x Genomics, Inc. v. Parse Biosciences, Inc., No. 22-1117-JHS, D.I. 224 (D. Del. June 06, 2024) (Parse Ltr. Requesting New Trial Date)

Record of Oral Teleconference Held on July 2, 2024

Order Conduct of the Proceeding

Email

Petitioner Parse Biosciences, Inc.'s Notice of John QuackenbushDeposition of

EX1067

Patent Owner's Response

EX2011 - Declaration of Sayem Osman

EX2012 - Parse Biosciences, Inc. v. 10x Genomics, Inc. IPR2023-00876, EX1002 (Apr. 20, 2023) (Declaration of Gregory Cooper, Ph.D.)

EX2013 - Declaration of Dr. John Quackenbush

EX2014 - Bruce Alberts, et al., Molecular Biology of the Cell, Garland Science (4th ed. 2002)

EX2015 - S. Guan, A. Blanchard, P. Zhang, & Z. Zhu, Alteration of Sequence Specificity of the Type IIS Restriction Endonuclease BtsI, (July 26, 2010)

EX2016 - Piovesan et al., On the length, weight, and GT content of the human genome, BMC Res. Notes 12:106 (2019)

EX2017 - T. Chauhan, T4 DNA Ligase: Introduction, Functions, Applications, and Protocol

EX2018 - IPR2023-00876 Deposition Transcript of Gregory Cooper, Ph.D.

EX2019 - Li et al., Amplification and analysis of DNA sequences in single human sperm and diploid cells, Nature 335(6189):414-417 (1998)

EX2020 - IPR2023-00955 Deposition Transcript of Gregory Cooper, Ph.D.

April 17, 2024 Joint Stipulation to Modify Due Dates 1, 2, and 3

Deposition Notice of Gregory Cooper, Ph.D.

ORDER Granting Petitioner’s Motions for Pro Hac Vice Admission of Edward R. Reines 37 C.F.R. § 42.10

Petitioner Parse Biosciences, Inc.'s Supplemental Mandatory Notice Adding Backup Counsel Under 37 C.F.R. Section 42.8(a)(3)

Petitioner Parse Biosciences, Inc.'s Supplemental Power of Attorney for Edward R. Reines

Petitioner Parse Biosciences, Inc.'s Motion for Admission Pro Hac Vice of Edward R. Reines Pursuant to 37 C.F.R. Section 42.10

Petitioner Parse Biosciences, Inc.'s Updated Exhibit List

Exhibit 1064 - Declaration of Edward R. Reines in support of pro hac vice motion

Exhibit 1065 - In re Reines Federal Circuit decision, 14-MA0004

Exhibit 1066 - Personal Statement of Edward R. Reines, Fed. Cir. 14-MA004

Patent Owner's Objections to Evidence

Institution Decision: granting institution on request for rehearing

SCHEDULING ORDER

Petitioner's Rehearing Request of the Board's Non-Institution Decision

EX1063

Denying Institution of Inter Partes Review 35 U.S.C. § 314

Patent Owner's Preliminary Response

EX2001 - File History of U.S. App. No. 15/677,957

EX2002 - File History of U.S. App. No. 13/859,450

EX2003 - Dictionary of Microbiology and Molecular Biology (2d ed. 1987)

EX2004 [PART 1] - File History of U.S. App. No. 14/792,094

EX2004 [PART 2] - File History of U.S. App. No. 14/792,094

EX2005 - File History of U.S. App. No. 13/387,343

EX2006 - U.S. Patent Pub. No. 2007/0238113

EX2007 - Laird et al., Hairpin-bisulfite PCR: assessing epigenetic methylation patterns on complementary strands of individual DNA molecules, 101 PNAS 204-09 (Dec. 12, 2003)

EX2008 - Parse Biosciences, Inc. v. 10x, Genomics Inc., IPR2023-00876, Pap.1 (April 20, 2023)

EX2009 - File History of U.S. App. No. 14/172,694

EX2010 - Declaration of Sayem Osman

Notice: Notice filing date accorded

Patent Owner's Power of Attorney & Designation of Lead and Back-Up Counsel

Patent Owner's Mandatory Notices

Petition for Inter Partes Review of U.S. Patent No. 10,240,197

U.S. Patent No. 10,240,197

Declaration of Gregory Cooper, Ph.D.

PCT Patent Publication No. WO 2010/117620 ("Linnarsson")

Megan L McCloskey et al., Encoding PCR Products ("McCloskey")

Prosecution File History of U.S. Patent No. 10,240,197

Leslie H. Brail et al., Gene expression in individual cells ("Brail")

Hubert Hug et al., Measurement of Number of Molecules ("Hug")

Gerald Schochetman et al., Polymerase Chain Reaction ("Schochetman")

H.C. Yang et al., A genome-wide study of preferential ("Yang")

Severine A Degrelle et al., Amplification biases ("Degrelle")

Brooks E. Miner et al., Molecular barcodes ("Miner")

U.S. Patent Provisional Application No. 61/164,759 ("Linnarsson Provisional

Defendant 10X Genomic's Opening Br ISO Mtn to Dismiss

Defendant 10X Genomic's Reply Br ISO Mtn to Dismiss

Scheduling Order, C.A. No. 22-1117-JHS D.Del.

Federal Judicial Caseload Statistics (2022)

Curriculum Vitae of Gregory Cooper

Jonas Binladen et al., The Use of Coded PCR Primers "Binladen"

Motion Success for Stay Pending IPR In Delaware District

Hiroto Okayama and Paul Berg, High-Efficiency Cloning ("Okayama")

Bruce Alberts, et al., Chapter 6 How Cells read the Genome

Assignment Record for U.S. Patent 8,298,767

10x Genomics Legal Notice

Declaration of Sylvia D. Hall-Ellis, Ph.D.

US Patent No. 8,835,358 B2

S. Clancy et al., Translation: DNA to mRNA to Protein

Cole Trapnell, Defining cell types ("Trapnell")

Gerard Brady et al., Representative in Vitro ("Brady")

James Eberwine et al., Analysis of gene expression ("Eberwine")

Maria de Fatima Bonaldo et al., Normalization and Subtraction ("Bonaldo")

Sydney Brenner et al., In vitro cloning of complex ("Brenner")

David H. Persing, Polymerase Chain Reaction ("Persing")

Kazuki Kurimoto et al., An improved single-cell cDNA ("Kurimoto")

Shigeyuki Esumi et al., Method for single-cell microarray ("Esumi")

Y. Shibata et al., Cloning Full-length ("Shibata")

U.S. Patent Application 2004/0166499

Athina Gkazi, An Overview of Next-Generation Sequencing

Rami Sukarieh, Relocalization of elF4E by its binding partners

Clyde A. Hutchinson, DNA sequencing ("Hutchinson")

Beata G Vertessy and Judit Toth, Keeping Uracil Out of DNA ("Vertessy")

Elaine R. Mardis, Next-Generation DNA ("Mardis")

Jay Shendure and Hanlee Ji, Next-Generation DNA Sequencing

Elaine R. Mardis, The impact of next-generation sequencing ("Mardis 2")

Robert A. Holt and Steven J.M. Jones, The new paradigm ("Holt")

National Human Genome Research Institute, Nucleotide

National Human Genome Research Institute, Polymerase Chain Reaction

Becton, Dickinson & Co. & Cellular Research, Inc.'s First Am Complaint

Exs 26 & 27 attached to Becton, Dickinson & Co. First Am Complaint

US 9,708,659 B2

Georgi K. Marinov et. al, From single-cell ("Marinov")

United States Patent Application Publication to McCloskey ("McCloskey II")

Boris Hollas & Rainer Schuler, A Stochastic Approach ("Hollas")

Thomas J Albert et al., Direct Selection of Human ("Albert")

US 7,537,897 B2

Reinhard Stoger, Epigenetics and Obesity ("Stoger")

Diane P. Genereux et. al, Errors in the Bisulfite ("Genereux")

Pierre Nicolas et. al., The Stem Cell Population ("Nicolas")

Notice : Parse Biosciences, Inc. Power of Attorney